Distinct Clinicopathological Features of HER2 ‐Negative, HER2 ‐Low, and HER2 ‐Overexpressing Urothelial Carcinoma in a Large Chinese Cohort

Documenti analoghi

• Prediction of HER2 ‐Low Breast Cancer via Multimodal Ultrasound Imaging
  di: Feihang Dai, et al.
  Pubblicazione: (2025)
• Prognostic implications of HER2NEU‐low in metastatic breast cancer
  di: Zachary Neubauer, et al.
  Pubblicazione: (2024)
• Machine learning‐based model constructed from ultrasound radiomics and clinical features for predicting HER2 status in breast cancer patients with indeterminate (2+) immunohistochemical results
  di: Meiying Yan, et al.
  Pubblicazione: (2024)
• Characterisation of HER2‐Driven Morphometric Signature in Breast Cancer and Prediction of Risk of Recurrence
  di: N. M. Atallah, et al.
  Pubblicazione: (2025)
• Nomograms for predicting recurrence of HER2‐positive breast cancer with different HR status based on ultrasound and clinicopathological characteristics
  di: Xudong Zhang, et al.
  Pubblicazione: (2024)